SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12,764.49 |
| Enterprise Value ($M) | 13,576.45 |
| Book Value ($M) | 961.19 |
| Book Value / Share | 10.17 |
| Price / Book | 13.28 |
| NCAV ($M) | 201.67 |
| NCAV / Share | 2.13 |
| Price / NCAV | 63.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.44 |
| Current Ratio | 4.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,464.86 |
| Assets | 3,224.39 |
| Liabilities | 2,263.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,243.34 |
| Operating Income | -267.82 |
| Net Income | -535.98 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -500.99 |
| Cash from Investing | -165.80 |
| Cash from Financing | 125.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 5.70 | -11.32 | |
| 13G/A | Vanguard Group Inc | 9.42 | 9.75 | |
| 13G | Capital International Investors | 5.10 | ||
| 13G/A | BlackRock Inc. | 6.70 | 12.77 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 380,213 | 1,892,731 | 20.09 | |
| 71,625 | 437,545 | 16.37 | |
| 115,534 | 1,196,284 | 9.66 | |
| 294,102 | 544,843 | 53.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SOPH – SOPHiA GENETICS SA | SPRB – Spruce Biosciences, Inc. |
| SPRO – Spero Therapeutics, Inc. | SRRK – Scholar Rock Holding Corporation |
| STOK – Stoke Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io